Form 4: Establishment Labs Director Acquires Shares in Lieu of Cash Retainer

Director Ann Custin acquired 426 common shares of Establishment Labs Holdings Inc. (ESTA) on June 30, 2024, in lieu of a quarterly cash retainer payment.

Summary

• On June 30, 2024, Ann Custin, a director of Establishment Labs Holdings Inc. (ESTA), acquired 426 common shares.
• The shares were received in lieu of a quarterly cash retainer payment, as per the Issuer's Outside Director Compensation Policy.
• The price of the shares was $45.44.
• Following the transaction, Custin directly owns 15,320 common shares.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transaction is a routine part of director compensation. The director taking shares instead of cash is a slightly positive signal.

Positives

• A director's decision to take shares instead of cash may signal confidence in the company's future performance.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. A director choosing to receive shares instead of cash compensation could be interpreted positively by the market.

Comparison to Industry Standards

• Comparing this transaction to other insider transactions within the medical aesthetics industry could provide context.
• For example, if directors at companies like Allergan (now AbbVie) or Galderma have similar compensation structures, it would suggest this is a common practice.
• Analyzing the frequency and size of insider transactions across the industry can help determine if this transaction is significant.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a director.

Key Dates